Norges Bank’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
SL
Norges Bank's ONC Position: Q2 2025 in Review
Norges Bank sold out of BeOne Medicines (ONC) in Q2 2025, closing a stake of 17,400 shares — an estimated $4.74M sold.
Norges Bank first reported a position in ONC in Q4 2016 and held it in 23 quarters. The position peaked at $126M in Q3 2021. 246 funds tracked by Wall St. Rank hold ONC as of Q2 2025.
- Norges Bank reported no remaining BeOne Medicines position as of Q2 2025 after selling out during the quarter.
- Norges Bank sold 17,400 BeOne Medicines shares in Q2 2025, an estimated $4.74M.
- Norges Bank first reported a position in BeOne Medicines in Q4 2016 and held it in 23 quarters.
- Norges Bank's BeOne Medicines position peaked at $126M in Q3 2021.
- 246 funds tracked by Wall St. Rank held BeOne Medicines as of Q2 2025.
Based on Norges Bank's 13F filing for Q2 2025, filed 13 Aug 2025.